GlassScriptPhysician profile
Brandon J Kai
NPI 1285913632
$3,164.34
in general payments reported to CMS, 2019-2025
15 companies · $680 in 2025
The $680 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,202 · 2020: $30.50 · 2021: $485 · 2022: $466 · 2023: $139 · 2024: $163 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $315.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,180.24 | 2019 | |
| Medtronic, INC. | $461.37 | 2022-2025 | Selectsecure |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.51 | 2021-2025 | Jardiance |
| W. L. Gore & Associates, INC. | $315.00 | 2025 | Product In Development |
| Astrazeneca Pharmaceuticals LP | $249.42 | 2021 | |
| Vapotherm INC | $124.40 | 2021 | |
| Lantheus Medical Imaging, INC. | $113.70 | 2019-2023 | Definity |
| Shockwave Medical, INC | $81.38 | 2025 | |
| Boston Scientific Corporation | $80.59 | 2024-2025 | General - Crm_crm, Resonate El Icd Vr, General - Therapies |
| E.R. Squibb & Sons, L.L.C. | $59.60 | 2023-2025 | Camzyos, Eliquis |
| Cvrx, INC. | $37.98 | 2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $32.32 | 2025 | |
| Pfizer INC. | $24.15 | 2025 | |
| Abiomed | $21.52 | 2024 | Impella |
| Alnylam Pharmaceuticals INC. | $21.16 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Kai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.